P55-74766-47652
4 vaccinations
1 coded response
9 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 440 / OH
- Registered
- 2021-12-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
PT9-84727-72306
Child or adolescent in my care · Male · 2022-06-26
Timeline
-
2021-02-25
Dose 1 — Moderna
-
2021-03-25
Dose 2 — Moderna
-
2021-11-15
Dose 3 — Moderna
-
2021-12-04
Registered in v-safe
- 2021-12-04
- 2021-12-08
- 2021-12-13
- 2021-12-22
- 2021-12-27
- 2022-02-14
-
2022-05-11
Dose 4 — Pfizer-BioNTech
- 2022-05-16
- 2022-06-26
-
2022-11-09
Survey response — 6 months, dose 4MedDRA: Cough, Dyspnoea — Feeling: Fair · Be unable to work or attend schoolFree text: Lingering cough, difficulty breathingMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-25 | Moderna | No |
| 2 | 2021-03-25 | Moderna | No |
| 3 | 2021-11-15 | Moderna | No |
| 4 | 2022-05-11 | Pfizer-BioNTech | No |
Free text
Release 12 — 6 months, dose 4
Symptoms: Lingering cough, difficulty breathing
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release